PDPHV-201401

N/A

Report date: 2024/04/28 18:06:23

Base Information

Drug NamePDPHV-201401

Drug Alias NameDNA prime + protein boost HIV-1 vaccinegp120 (A, B, C, A/E) Protein Vaccine + env (A, B, C, A/E)/gag (C) DNA VaccineEnv (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV VaccinesPDPHVPolyvalent DNA/Protein HIV Vaccine +[6]

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Massachusetts Medical School

China Registration ClassN/A

Develop Information

Active CompaniesWorcester HIV Vaccine

Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A